U.S. stock futures edge higher; earnings season continues
Earth Science Tech, Inc. (OTC:ETST), a Florida-based biotechnology company with a market capitalization of $34.35 million, announced the continuation of employment agreements for two key executives, as per a recent filing with the U.S. Securities and Exchange Commission. The company, which has achieved impressive revenue growth of 409% over the last twelve months and maintains a healthy gross margin of 72%, appears undervalued according to InvestingPro analysis. On March 11, 2025, the company’s board and compensation committee agreed to extend the contracts for Chief Financial Officer Ernesto L. Flores and Chief Technology Officer Christopher Rose.
Flores, who also serves as Treasurer, Chairman of the Compensation Committee, and a member of the Audit Committee, will retain his annual base salary of $160,000, which is paid in biweekly installments. Similarly, Rose will continue to receive an annual base salary of $270,000, also distributed biweekly. With the company reporting positive earnings of $0.01 per share in the last twelve months, InvestingPro data reveals 12 additional key insights about ETST’s performance and outlook.
Both executives are eligible for additional performance-based bonuses, the amounts of which are determined at the discretion of the Chief Executive Officer. The company did not disclose specific performance metrics or targets associated with these potential bonuses.
This financial information is based on a press release statement from Earth Science Tech, Inc. The company, operating under the pharmaceutical preparations industry, is known for its work in the development of nutraceuticals and pharmaceuticals. According to InvestingPro analysis, ETST maintains a GREAT financial health score of 3.57, suggesting strong operational performance and stability.
The announcement does not suggest any changes to the company’s strategic direction or operational focus. It appears to be a routine disclosure of executive compensation, which is a standard practice for publicly traded companies to ensure transparency with shareholders and the public.
Investors and stakeholders in Earth Science Tech can view the full details of the employment agreements and other financial statements as part of the company’s public filings. Earth Science Tech’s shares are traded over the counter, providing an alternative trading platform to the traditional stock exchanges.
In other recent news, Earth Science Tech, Inc. has amended the terms of its acquisition agreement with Las Villas Healthcare, LLC and Doconsultations.com, LLC. According to a recent 8-K filing with the U.S. Securities and Exchange Commission, the total purchase price has been reduced from $400,000 to $200,000. The initial agreement, dated January 30, 2025, included a payment of $50,000 to the targets, with the remaining $150,000 to be paid at the closing of the transaction. This closing is anticipated to occur after a ninety-day due diligence period, which is currently underway. The reduction in purchase price marks a significant change in the financial terms of the acquisition. This development is part of Earth Science Tech’s broader strategy to expand its operations within the healthcare sector. The amendment details have been made public to comply with regulatory requirements and to inform shareholders and potential investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.